This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Rights and permissions
About this article
Cite this article
McCormick, D., Moon, R. Inhibition of mammary carcinogenesis by flurbiprofen, a non-steroidal antiinflammatory agent. Br J Cancer 48, 859–861 (1983). https://doi.org/10.1038/bjc.1983.278
Issue Date:
DOI: https://doi.org/10.1038/bjc.1983.278
This article is cited by
-
N-Methyl-N-nitrosourea as a mammary carcinogenic agent
Tumor Biology (2015)
-
Bortezomib in combination with celecoxib in patients with advanced solid tumors: a phase I trial
BMC Cancer (2007)
-
In vitro effects of eicosanoid synthesis inhibitors in the presence of linoleic acid on MDA-MB-231 human breast cancer cells
Breast Cancer Research and Treatment (1996)
-
The influence of dietary medium chain triglycerides on rat mammary tumor development
Lipids (1987)